Kv channels contain a central pore domain 1,2 that opens and closes in response to conformational changes in the four surrounding voltagesensing domains 3 . Each subunit in these tetrameric channels has six membrane-spanning segments (S1 through S6), with S1-S4 comprising each voltage-sensing domain and the four S5-S6 regions together forming the central pore domain. X-ray structures of these channels predict that the S1-S4 voltage-sensing domains would be extensively exposed to surrounding lipids when embedded in a membrane 1, 4 , and functional studies demonstrate that changing the composition of the lipid membrane can have striking effects on how these channels open and close in response to changes in voltage [5] [6] [7] [8] [9] [10] . In studies on the KvAP channel from Aeropyrum pernix reconstituted in defined lipid membranes, lipids with phosphate-containing head groups are required for channel activation 5 , leading to the proposal that arginine residues in the voltage sensor are stabilized in the membrane by interactions with phosphate lipid head groups. Experiments in native lipid membranes 6, 7 indicate that the phosphate head group of sphingomyelin has a similar role in the activation of the well-studied Shaker Kv channel from Drosophila melanogaster 11 and the mammalian Kv2.1 channel from rat brain 12 . Modification of sphingomyelin does not influence the gating of several other related Kv channels 6 , suggesting that there is specificity in the interaction between lipids and Kv channels. In the case of Kv2.1, the effects of modification of sphingomyelin can be diminished by toxins that bind to voltage sensors 7 , raising the possibility that sphingomyelin interacts directly with voltage sensors in the channel, perhaps similarly to the non-annular lipids observed for other membrane proteins 13, 14 . In the present study we set out to determine whether sphingomyelin interacts with the voltage-sensing domains in Kv2.1 channels and to identify specific regions where the lipid might bind. Our results suggest that sphingomyelin interacts with a particular structural motif within voltage sensors and that these interactions can influence the pharmacological sensitivities of the channel.
a r t i c l e s
Kv channels contain a central pore domain 1, 2 that opens and closes in response to conformational changes in the four surrounding voltagesensing domains 3 . Each subunit in these tetrameric channels has six membrane-spanning segments (S1 through S6), with S1-S4 comprising each voltage-sensing domain and the four S5-S6 regions together forming the central pore domain. X-ray structures of these channels predict that the S1-S4 voltage-sensing domains would be extensively exposed to surrounding lipids when embedded in a membrane 1, 4 , and functional studies demonstrate that changing the composition of the lipid membrane can have striking effects on how these channels open and close in response to changes in voltage [5] [6] [7] [8] [9] [10] . In studies on the KvAP channel from Aeropyrum pernix reconstituted in defined lipid membranes, lipids with phosphate-containing head groups are required for channel activation 5 , leading to the proposal that arginine residues in the voltage sensor are stabilized in the membrane by interactions with phosphate lipid head groups. Experiments in native lipid membranes 6, 7 indicate that the phosphate head group of sphingomyelin has a similar role in the activation of the well-studied Shaker Kv channel from Drosophila melanogaster 11 and the mammalian Kv2.1 channel from rat brain 12 . Modification of sphingomyelin does not influence the gating of several other related Kv channels 6 , suggesting that there is specificity in the interaction between lipids and Kv channels. In the case of Kv2.1, the effects of modification of sphingomyelin can be diminished by toxins that bind to voltage sensors 7 , raising the possibility that sphingomyelin interacts directly with voltage sensors in the channel, perhaps similarly to the non-annular lipids observed for other membrane proteins 13, 14 . In the present study we set out to determine whether sphingomyelin interacts with the voltage-sensing domains in Kv2.1 channels and to identify specific regions where the lipid might bind. Our results suggest that sphingomyelin interacts with a particular structural motif within voltage sensors and that these interactions can influence the pharmacological sensitivities of the channel.
RESULTS
We investigated how sphingomyelinase D (SMaseD), an enzyme that converts sphingomyelin to ceramide-1-phosphate, influences the gating and pharmacological sensitivities of the Kv2.1 channel from rat brain 12 . Lu and colleagues reported that this Kv channel is particularly sensitive to the lipase 6 , with removal of the choline moiety of sphingomyelin causing the channel to open at voltages at which it would otherwise be closed 6 . Application of SMaseD to the extracellular side of cells expressing Kv2.1 caused a −30-mV shift of the conductancevoltage (G-V) relation (Fig. 1a) that developed over 10-15 min and was not reversible over the time frame of our recordings (>1 h), consistent with previous results 6 . Deactivation of the channel following membrane repolarization was greatly slowed after SMaseD treatment (Fig. 1a) , indicating that the lipid modification causes a pronounced stabilization of the open state of the channel.
Lipid modification alters voltage sensor activation
To explore whether the effects of SMaseD result from interactions between lipids and the S1-S4 voltage-sensing domain of the channel, we asked whether the lipase has similar effects on another protein containing an S1-S4 voltage-sensing domain but lacking a pore domain. For these experiments we used the Ciona intestinalis voltage-sensitive a r t i c l e s phosphatase (Ci-VSP), which contains a cytoplasmic phosphatase domain rather than a transmembrane pore 15 , and monitored activation of its S1-S4 voltage-sensing domain by measuring charge movement in response to membrane depolarization [15] [16] [17] . Extracellular application of SMaseD to cells expressing Ci-VSP produced an approximately -20-mV shift of the charge-voltage (Q-V) relationship to more negative voltages (Fig. 1b) . As in the case of Kv2.1, the effects of the enzyme developed over 10-15 min and were effectively irreversible. These results demonstrate that modification of sphingomyelin can influence the activity of S1-S4 voltage-sensing domains in the absence of a pore domain.
S3b-S4 paddles determine the effects of lipid modification
One interesting candidate for a region within S1-S4 voltage-sensing domains that interacts with lipids is the S3b-S4 paddle motif, a helixturn-helix motif that moves in contact with the lipid membrane to sense changes in voltage 3, 4, 8, [18] [19] [20] [21] [22] . To explore the possibility that sphingomyelin interacts with the paddle motif, we measured the effects of SMaseD on Kv2.1 chimeras containing paddle motifs from various voltage-activated ion channels (Fig. 1c,d ). Of the constructs we studied, those containing paddle motifs from the four different voltage-sensing domains of the rat skeletal muscle Nav1.4 sodium channel 23 were the most informative. These Nav channel paddle motifs were capable of gating the Kv2.1 channel and rendering the Kv channel sensitive to Nav channel toxins 21 ; however, SMaseD altered the G-V relations of the chimeras to different extents (Fig. 1d) . In particular, Kv channels containing the paddle motif from domain I of Nav1.4 were effectively insensitive to SMaseD, suggesting that the paddle motifs determine the sensitivity of the channel to lipid modification.
Lipid modification alters voltage sensor pharmacology
If the membrane lipids studied here actually bind to paddle motifs in Kv channels, it is possible that the binding of other ligands at the protein-lipid interface would be influenced by lipid modification. Because tarantula toxins partition into membranes 9, [24] [25] [26] ( Supplementary Fig. 1 ) and bind to regions of the paddle motif facing the surrounding membrane 1, 8, 10, 21, [27] [28] [29] , we investigated whether their interaction with the paddle motif is altered by lipid modification. We studied the effects of SMaseD on the interaction of the GxTx-1E 30 toxin with the wild-type Kv2.1 channel, VSTx1 (refs. 25,31) with a chimera produced by transplanting the S4 helix from KvAP into Kv2.1 (KvAP[S4]) 8 and ProTx-I 32 with the two Nav paddle chimeras that are sensitive to the toxin 21 (Fig. 2) . The lipid modification produced a 3.9-fold increase in the apparent affinity of GxTx-1E for Kv2.1 (Fig. 2a) and a 6.2-fold increase in that of VSTx1 for the KvAP chimera (Fig. 2b) . The effects of ProTx-I on the two Nav paddle chimeras are particularly noteworthy, as the apparent affinity of the toxin is increased by only 50% for the domain II chimera (Nav DII [S3-S4]) but by more than six-fold for the domain IV chimera (Nav DIV [S3-S4]) (Fig. 2c,d ). These effects of SMaseD on the interactions of tarantula toxins with paddle motifs demonstrate that the toxins can sense the lipid modification.
The distinct effects of the lipase on ProTx-I interaction with the two Nav paddle chimeras suggest that the modification does not simply alter the way these toxins interact with lipids (for example, by altering the toxin concentration in the membrane) but that the toxins can actually detect differences in the way lipids interact with distinct paddle motifs. To confirm that partitioning of tarantula toxins is not altered by SMaseD, we compared partitioning of 125 I-GxTx-1E into intact oocyte membranes 9 before and after lipid modification. At a concentration of GxTx-1E (200 nM) that completely inhibited opening of Kv2.1 (Fig. 2a) , partitioning of the toxin was unaffected by SMaseD treatment (Fig. 2e) .
Tarantula toxins detect lipid-paddle interactions
Previous studies have shown that tarantula toxins interact with the paddle motif in a specific fashion, with mutations in the for the Nav DI and Nav DII chimeras and −120mV for the Nav DIII and NavDIV chimeras, the test pulse duration was 300 ms (500 ms for Nav DIV) and the tail voltage was −60mV for Nav DI, −80mV for Nav DII, −110mV for Nav DIII and −100mV for Nav DIV. (d) G-V curves for chimeras where complete (S3-S4) or partial (S4) paddle motifs of Kv2.1 were replaced with homologous regions from KvAP. The holding voltage was −100mV, the test pulse duration was 300 ms and the tail voltage was −80mV. In all cases conductance was determined from normalized tail currents. For ionic currents, leak, background and capacitive currents were isolated and subtracted after blocking the Kv channels with agitoxin-2; for gating currents, they were subtracted using a P/-4 protocol. Error bars indicate s.e.m. (n = 3).
a r t i c l e s paddle having pronounced effects on the apparent affinity of these toxins 8, 10, 21, 26, 27, 29, 33 . The idea that both lipids and toxins interact with the the paddle motif raises the intriguing possibility that mutations in the paddle might alter toxin affinity by disrupting lipid-paddle interactions. In search of such mutations, we substituted each residue in the paddle motif of Kv2.1 with alanine and measured the apparent affinity of GxTx-1E for these channels in control membranes and after treatment with SMaseD. Mutations such as V282A and E277A decreased the apparent affinity of the toxin when studied in untreated membranes, but did so to a lesser extent after lipid modification (Fig. 3a) . In the case of V282A, the mutant weakened toxin affinity by more than 18-fold under control conditions, but by only about two-fold after treatment with the lipase. In this instance, the extent to which the mutation weakens toxin affinity is markedly dependent on the lipids around the channel, suggesting that the mutation actually influences how lipids interact with the paddle motif. Another way of looking at this result is to consider that for the wild-type channel lipid modification increased toxin affinity by only about four-fold; however, after the paddle mutation is introduced, weakening toxin binding, addition of the lipid modification increased toxin affinity by more than 30-fold (Fig. 3a, Supplementary Fig. 2 and Supplementary  Tables 1 and 2 ). Thus, it seems that the lipid modification can correct the disruptive effects of the mutation (see Discussion). The E277A mutant is an example where the effect of the mutation on toxin affinity is moderately different between control and SMaseDtreated membranes, even though the mutant alters the affinity of the toxin by almost 150-fold when studied in control membranes (Fig. 3a) . In this instance, the mutant seems to weaken toxin affinity largely by altering a protein-protein interaction, and the lipid modification can only modestly correct the effects of the mutation. The extent to which the lipid modification and paddle mutations are coupled can a r t i c l e s be evaluated for all mutations by plotting the mutation-induced perturbation in toxin affinity for control membranes (K d mut /K d wt ) against that for SMaseD-treated membranes (Fig. 3b,c) . F285A, I273A, S278A and L283A are examples where the lipid modification largely corrects the weakening of toxins affinity, as described above for V282A. In other cases, the effects of the mutations are unaltered by lipid modification, regardless of whether the effects of the mutation on toxin affinity are small (for example, I297A, Q286A and R290A) or large (for example, S281A and R296A), indicating that there is specificity in the coupling between the lipid modification and the paddle mutations.
To understand where on the paddle motif these lipid interactions occur, we calculated the free energy associated with the coupling between channel mutations and the lipid modification 34, 35 (∆G coupling ; Supplementary Fig. 2 ) and mapped them onto the X-ray structure of the Kv2.1-Kv1.2 paddle chimera 1 , a structure in which the voltage sensor is activated and the pore is open. Using a continuous color gradient between white and red to represent increasing |∆G coupling |, we can see that mutations that are coupled with the lipid modification tend to concentrate in two regions of the paddle motif (Fig. 4) . The first is on the surface of the S3b helix that projects out toward the surrounding bilayer (Fig. 4a,b) , and the second is on the surface of the S4 helix facing the S5 helix from the adjacent subunit (Fig. 4c) . Residues at the interface between the S3b and S4 helices are notable in that their mutation does not couple to the lipid modification (Fig. 4d) . Further experiments using VSTx1 as a detector to measure coupling between S4 mutations in the KvAP[S4] chimera and lipid modification identify a similar face of the S4 helix where coupling occurs (Supplementary Figs. 3 and 4 and Supplementary Table 3 ), demonstrating that lipids can interact with similar regions of S4 in distantly related Kv channels.
DISCUSSION
The goal of the present study was to explore the interaction of sphingomyelin with S1-S4 voltage-sensing domains and the role of the lipid in the function and pharmacology of Kv channels. Our experiments with Ci-VSP establish that modification of sphingomyelin can influence the S1-S4 voltage-sensing domains in the absence of a pore domain (Fig. 1b) , and the results with paddle chimeras point to interactions between the lipid and the paddle motif (Fig. 2) . In testing the idea that sphingomyelin may act similarly to a non-annular lipid and bind to the paddle motif, we investigated whether tarantula toxins can sense modification of the lipid. SMaseD treatment typically increases the apparent affinity of these toxins, but the extent varies greatly for different toxin-paddle combinations (Fig. 2) and, in particular, for mutations on the paddle motif of Kv2.1 (Fig. 3) . The lipid modification does not influence the interaction of the toxin with the bulk membrane (Fig. 2) , suggesting that toxin detects a local alteration near where it binds to the paddle motif. These results demonstrate that the pharmacological sensitivity of an ion channel can be profoundly influenced by the identity of lipids around the channel and their interactions with specific structural motifs. Residues in the S1-S2 loop were removed for clarity and all structures were drawn using PyMol (DeLano Scientific).
How does the modification of sphingomyelin alter the sensitivity of Kv2.1 to tarantula toxins? It seems likely that the effects of SMaseD are not simply the consequence of removing sphingomyelin, because conversion of the lipid to either ceramide-1-phosphate with SMaseD or to ceramide with SMaseC has different effects on the gating of Kv2.1. The former facilitates opening 6 (Fig. 1) , whereas the latter creates a barrier to opening of the channel 7 . It is unlikely that the effects of the lipase on toxin affinity are secondary to the dissociation of sphingomyelin-rich lipid microdomains (rafts) because mutations in the paddle motif couple with the lipid modification (Fig. 3) . In addition, dissociation of these microdomains with cholesterol depletion does not influence activation of Kv2.1 channels 6, 36 or sensitivity of the channel to tarantula toxins (not shown). One way to explain the effect of lipid modification on toxin affinity would be to postulate that tarantula toxins bind to the paddle motif with higher affinity when sphingomyelin is bound ( Fig. 5; K d ′ < K d ) ). In this way, mutations could weaken toxin binding by disrupting lipid-paddle interactions, rather than by altering a protein-protein interaction between toxin and channel (Fig. 3a) . In the context of this model, lipid modification could rescue high-affinity toxin binding after mutations weaken lipidpaddle interactions either because the interaction of the modified lipid is stronger (lower K L ) or because the toxin binds more strongly to paddles interacting with ceramide-1-phosphate than to paddles interacting with sphingomyelin.
Where on the paddle motif do the lipids bind? Our experiments using tarantula toxins as detectors uncovered surfaces of both the S3b and S4 helices within the paddle motif where mutations couple with the lipid modification (Fig. 4) . Interactions between lipids and the S3b helix are interesting because these might help to anchor the helix near the membrane surface, which would be consistent with studies showing that residues in S3b do not show substantial changes in accessibility to water-soluble agents during gating [37] [38] [39] . Interaction of lipids with the surface of S4 that faces S5 is an ideal location to maximize electrostatic interactions between phosphate lipid head groups and the outer S4 arginine residues to stabilize the voltage sensor in an activated state [5] [6] [7] . These protein-lipid interactions at the interface between the voltage-sensing and pore domains could explain why S5 mutants in this region can hinder voltage sensor activation 40 , even though the S4 and S5 helices do not pack together tightly in X-ray structures 1, 41 . The presence of bound lipids between S4 and S5 is consistent with the general picture whereby non-annular lipids bind to membrane proteins at interfaces between transmembrane helices 13, 14 . Although structural information on sphingolipidbinding proteins is limited, helix-turn-helix motifs reminiscent of the paddle motifs found in voltage sensors have been proposed to bind these lipids 42, 43 .
Our observations concerning the sensitivity of Kv channel pharmacology to lipids fit nicely with the discovery that Kv channel pharmacology can also be modulated by the mechanical properties of the membrane 10 . The important implication is that the pharmacology of the ion channel is not determined by the protein alone, but by the lipids in the surrounding membrane and how they interact with the channel protein. It will be fascinating to explore whether variations in the composition and properties of membranes in different subcellular compartments, cell types or pathophysiological conditions influence the gating properties and pharmacological sensitivities of voltage-activated ion channels.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
ONLINE METHODS
Electrophysiological recording. We carried out expression of Kv channel and Ci-VSP constructs in Xenopus laevis oocytes and studied them using twoelectrode voltage-clamp recording techniques (OC-725C, Warner Instruments) as described 33 . Data were filtered at 1 kHz and digitized at 10 kHz. Microelectrode resistances were 0.1-1 MΩ when filled with 3M KCl. For ionic current measurements, the external recording solution contained 50 mM KCl, 50 mM NaCl, 5 mM HEPES, 1 mM MgCl 2 and 0.3 mM CaCl 2 , pH 7.6 (with NaOH). For gating current measurements on Ci-VSP, the external recording solution contained 100 mM NaCl, 10 mM HEPES, 1 mM MgCl 2 and 0.3 mM CaCl 2 , pH 7.6 (with NaOH). Recombinant SMaseD (final concentration 8 ng µl -1 ) was added to the recording chamber for 10-15 min, as described 6 , using weak depolarizations elicited at 3-s intervals to monitor the effects of the enzyme. After reaching equilibrium, the oocyte was washed extensively with the recording solution. We performed all experiments at room temperature (~22 °C). We synthesized GxTx-1E and VSTx1 using solid-phase chemical methods, as described 25 and purchased ProTx-I from Peptides International. We obtained conductance-voltage relations from tail currents measured after a series of membrane depolarizations. For a few mutants that showed fast deactivation kinetics, we calculated conductance from steady-state current measurements.
Estimating toxin occupancy of channels. We examined the occupancy of closed or resting channels by toxins using negative holding voltages where the open probability is low, and we estimated the fraction of unbound channels (F u ) using depolarizations that are too weak to open toxin-bound channels ( Supplementary  Fig. 5 ), as described 26, 27, 29, 33, 44, 45 . For all channels, we recorded voltage-activation relationships in the absence and presence of different concentrations of toxin. We calculated the ratio of currents (I/I 0 ) recorded in the presence (I) and absence (I 0 ) of toxin for various strength depolarizations, typically −70 mV to +10 mV, and the value of I/I 0 measured in the plateau phase at voltages where toxin-bound channels do not open was taken as F u (Supplementary Fig. 5 ). For all the experiments, voltage protocols were adjusted appropriately so that the plateau phase in the I/I 0 -voltage relationship was well defined. The apparent K d was calculated assuming four independent toxin-binding sites per channel, with single occupancy being sufficient to inhibit opening in response to weak depolarizations: 
